Metabolic syndrome and risk of prostate cancer: a systematic review and meta-analysis

CONCLUSIONS: Growing evidence support the association between metabolic syndrome and prostate cancer, bias derived from observational studies might conceal further findings.PMID:34859640 | DOI:10.23736/S0031-0808.21.04507-9

Source: Panminerva Medica - December 3, 2021 Category: General Medicine Authors: Giovanni Motterle Luca DE Zorzi Giovanni Zecchini Francesco G Mandato Giordana Ferraioli Marta Bianco Nicola Zanovello Source Type: research